100
Participants
Start Date
September 13, 2017
Primary Completion Date
June 1, 2019
Study Completion Date
June 1, 2022
Carfilzomib, Thalidomide and Dexamethasone
"Carfilzomib will be given on days 1,2,8,9,15,16 in a 4-week (28 day) cycle during induction cycles 1-12, followed by days 1,2,15,16 in a 4-week cycle during maintenance cycles 13-18 (section 4.0) Dexamethasone, 40mg po will be given on days 1,8,15, 22 in a 4-week cycle during induction cycles 1-12, followed by days 1,15, in a 4-week cycle during maintenance cycles 13-18.~Thalidomide, 100mg po will be given daily during induction cycles 1-12 only."
NOT_YET_RECRUITING
Queen Mary Hospital, Hong Kong
RECRUITING
National University Hospital, Singapore
NOT_YET_RECRUITING
South Korea
NOT_YET_RECRUITING
National Taiwan University, Taipei
Collaborators (1)
The Australasian Leukaemia & Lymphoma Group (ALLG)
UNKNOWN
International Myeloma Foundation
OTHER
Celgene
INDUSTRY
National University Hospital, Singapore
OTHER